AbbVie and Eisai obtain additional approval for Humira

The monoclonal antibody, Humira, is used in the treatment of patients who have had an inadequate response to conventional therapy for pustular psoriasis

picture of

Breaking News

Cell and Gene Therapy Catapult announces major UK investment in skills and capabilities

£3 million in Government investment to drive forward the Life Sciences Industrial Strategy via apprenticeships and ...

Life Sciences sector responds to report on the impact of Brexit

The Business, Energy and Indsutrial Strategy (BEIS) Committee report calls on the Government to secure a post-Brexit ...

Risankizumab approval could strengthen AbbVie's market position

According to GlobalData, if approved, risankizumab would further strengthen AbbVie’s position in the psoriasis market

GDPR versus privacy: what you need to know

Collecting and sharing data from clients and customers is a mandatory element of driving today’s business, but ...

Ixico signs contract with top 10 pharma company

The deal will provide specialist imaging clinical trial services for trial participants with Huntington’s disease

GE accelerates production of viral vector based therapeutics

GE Healthcare has launched a new factory-in-a-box, designed to accelerate the manufacture of products requiring a ...

Standing strong

As regulatory pressure keeps rising, affecting every aspect of the drug manufacturing process, quality is an ongoing ...

ERT receives sixth consecutive award for outstanding customer service

Remains committed to exceeding expectations, driving high satisfaction

Phoenix Molecular Designs announces manufacturing collaboration with WuXi STA

Phoenix Molecular Designs (PhoenixMD), a privately held biotechnology company designing precise cancer therapeutics by ...

Serialisation: a new challenge with new and specific requirements

TraceLink recently launched its Global Drug Supply, Safety and Traceability Report, which included the results of a ...

Serialisation: one year and counting

The Falsified Medicines Directive (FMD) introduces pan-European measures to prevent counterfeit medicines from entering ...

Clinical evaluation: three actions for improved medical device trials and compliance

The way we plan and conduct clinical investigations for medical devices must be adjusted to 21st century standards

Chinese pharma regulatory reforms will help to attract foreign investment

China is the second largest pharmaceutical market in the world

TraceLink unveils EU FMD Express: a purpose-built compliance solution for smaller pharmaceutical companies

TraceLink, the world’s largest track and trace network for connecting the life sciences supply chain and providing real- ...